Individual decision · SEC · 17 Nov 2005

SEC Division of Corporation Finance no-action letter: Shire Pharmaceuticals Group PLC and Shire PLC

2 files · 17 PDF pages

The Division will not object if New Shire files post-effective amendments to Shire's effective registration statements on Form S-3, Form S-4, and Form S-8 under Rule 414. New Shire may rely on Shire's reporting history to determine eligibility for these forms and to satisfy Rule 144 requirements regarding public information, trading volume limits, and holding periods. New Shire may register its common stock under the Exchange Act using Rule 12g-3(a), and holders of Schedule 13D or 13G reports are exempt from filing additional statements provided they note New Shire as the successor. The Division will not recommend enforcement action if New Shire does not register guarantees of Shire's Convertible Notes or qualify the supplemental indenture under the Trust Indenture Act, and New Shire may be treated as subject to Exchange Act reporting for Rule 174(b) exemptions.

US FederalSecurities and Exchange Commission
Enclosure 1 of 1 · 17 pages · PDF 77 KBRegulator's file ↗

Incoming Letter

Annotations and obligations
20 obligations · 39 permissions · 35 definitions
  1. Main text
  2. Incoming Letter
  • Obligation 20
  • Permission 39
  • Definition / condition 35
  • background, boilerplate

More like this from SEC

SEC published 7 documents in the last 30 days. We email you each new one the day it's published.

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated